Hims & Hers is getting into the at-home blood testing business
After having massive success with off-brand weight-loss drugs, the millennial-focused telehealth company Hims & Hers (HIMS) ...
3 Hot Stocks That Have Already Doubled in 2025
It may be early, but some blazing investments have already delivered wealth-altering gains in this young year.
Hosted on MSN1d
2025 USA TODAY Ad Meter Marketing Spotlight: Suffolk University's top 5 and bottom 5
Suffolk University unveils its top 5 and bottom 5 for the 2025 USA TODAY Ad Meter Marketing Spotlight. See which Super Bowl ...
Le Lézard4d
Verve Medical Cosmetics Celebrates 25th Anniversary by Offering Tips For Choosing The Right Injectables Provider
VERVE Medical Cosmetics, New York's premier non-surgical medical spa and anti-aging treatment studio has been helping clients manage the aging process with immediate, natural results through the use ...
The surprising link between cannabis and better orgasms – how weed can improve your sex life
As a growing body of research points to the potential for cannabis as a catalyst for climax, WH asks if this is the year that ...
Hims & Hers Stock Drops as FDA Says Ozempic and Wegovy No Longer in Short Supply
Shares of Hims & Hers Health plunged Friday after the Food & Drug Administration said a shortage of the active ingredient in ...
Why Is HIMS Stock Dropping Today?
The U.S. FDA has officially declared that Novo Nordisk’s (NVO) popular diabetes and weight loss therapies, Ozempic and Wegovy ...
Hims & Hers Q4 Preview: Is The Super Bowl Ad Worth $5B In Market Cap? (Rating Downgrade)
Investors could be overestimating the contribution of Hims & Hers' compounded GLP-1 medications to its top line. Read why I ...
What's Going On With Hims & Hers Health Stock Today?
Hims & Hers Health acquired a peptide facility to strengthen its U.S. supply chain and meet demand for personalized ...